Your browser doesn't support javascript.
loading
Understanding the patient's experience of coeliac disease diagnosis: a qualitative interview study.
Harper, Alice M; Watson, Jessica; O'Donnell, Rachel; Elwenspoek, Martha Mc; Banks, Jonathan.
Afiliação
  • Harper AM; Centre for Academic Primary Care, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol.
  • Watson J; Centre for Academic Primary Care, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol.
  • O'Donnell R; NIHR Applied Research Collaboration West, Population Health Sciences, Bristol Medical School, Bristol.
  • Elwenspoek MM; NIHR Applied Research Collaboration West, Population Health Sciences, Bristol Medical School, Bristol.
  • Banks J; NIHR Applied Research Collaboration West, Population Health Sciences, Bristol Medical School, Bristol.
Br J Gen Pract ; 74(739): e71-e77, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38191567
ABSTRACT

BACKGROUND:

Coeliac disease (CD) presents with non-specific symptoms, and delays to diagnosis are common. The traditional diagnostic pathway involves serological testing followed by endoscopic biopsy; however, the evidence is increasing about the effectiveness of a diagnosis without the need for a biopsy.

AIM:

To understand the patient's experience of being diagnosed with CD. DESIGN AND

SETTING:

A qualitative study was conducted, which involved semi-structured interviews with adults diagnosed with CD living in the UK.

METHOD:

Participants (n = 20) were purposefully sampled from 200 adults who had completed a diagnostic confidence survey. Interviews were conducted via video-conferencing software (Zoom), recorded, and transcribed verbatim. Data were analysed using reflexive thematic analysis.

RESULTS:

Interviewees faced pre-diagnostic uncertainty, presenting with non-specific symptoms that many experienced for several years and may have normalised. GPs often attributed their symptoms to alternative diagnoses, commonly, irritable bowel syndrome or anaemia. Investigations caused further uncertainty, with half of the interviewees unaware that their initial serology included a test for CD, and reporting long waits for endoscopy and challenges managing their diet around the procedure. Their uncertainty reduced once they received their biopsy results. Endoscopy was presented as the 'gold standard' for diagnosis and most interviewees believed that the procedure was necessary for diagnostic confidence and conviction in a lifelong gluten-free diet.

CONCLUSION:

Patients experience uncertainty on the pathway to a diagnosis of CD. GPs could improve their experiences by being mindful of the possibility of CD and sharing information about serological testing. Policy and guidance should address the time to endoscopy and diet during diagnosis. If diagnosis without biopsy is adopted, then consideration should be given to clinical pathway implementation and communication approaches to reduce patient uncertainty.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Celíaca Tipo de estudo: Diagnostic_studies / Guideline / Qualitative_research Limite: Adult / Humans Idioma: En Revista: Br J Gen Pract Ano de publicação: 2024 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Celíaca Tipo de estudo: Diagnostic_studies / Guideline / Qualitative_research Limite: Adult / Humans Idioma: En Revista: Br J Gen Pract Ano de publicação: 2024 Tipo de documento: Article País de publicação: Reino Unido